Cambrian Bioworks raises $1.45 Mn in seed round

Bengaluru-based biotechnology firm Cambrian Bioworks has secured $1.45 million in its seed round led by the Irani family office, which has invested in several private ventures across the globe. The round also saw participation from the company’s CEO and co-founder, Vaibhav Hegde. 

The proceeds will be used to ramp up development of Cambrian’s automated molecular diagnostics platforms, R&D efforts, expand the team, and support forays into international markets.

Founded by Hegde, Rohit Asil, and Raghav Sridhar, Cambrian Bioworks develops automated molecular diagnostic platforms. Its products find applications in oncology, genomics, rare disease testing, and AMR detection.

Recently, the firm launched Cambrian’s nucleic acid extraction platform, Manta which provides high-quality DNA/RNA for genomics and PCR testing in hospitals and laboratories. 

This is yet another example of a founder investing in his own startup. This trend started with the founders of Byju’s, OYO, and BluSmart, and has recently continued with investments from the founders of Yubi and Ather Energy.